We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$199M
AUM Growth
-$34.6B
(-99%)
Cap. Flow
-$35.1B
Cap. Flow
% of AUM
-17,587.21%
Top 10 Holdings %
Top 10 Hldgs %
62.92%
Holding
1,077
New
–
Increased
3
Reduced
57
Closed
1,016
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.03M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.53M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.49B |
| 2 |
Microsoft
MSFT
|
+$2.09B |
| 3 |
Apple
AAPL
|
+$1.44B |
| 4 |
Amazon
AMZN
|
+$1.36B |
| 5 |
Meta Platforms (Facebook)
META
|
+$721M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.46% |
| 2 | Technology | 21.6% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 10.02% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Dr. Reddy's Laboratories
RDY
$9.62B
| – | – |
-77,970
| Closed | -$1.17M |
|
827
Regency Centers
REG
$13.6B
| – | – |
-176,966
| Closed | -$12.6M |
|
828
Regeneron Pharmaceuticals
REGN
$79.7B
| – | – |
-62,430
| Closed | -$32.8M |
|
829
Rexford Industrial Realty
REXR
$8.61B
| – | – |
-109,871
| Closed | -$3.91M |
|
830
Regions Financial
RF
$25.3B
| – | – |
-233,739
| Closed | -$5.5M |
|
831
Rivian
RIVN
$22.5B
| – | – |
-67,436
| Closed | -$927K |
|
832
Raymond James Financial
RJF
$32.5B
| – | – |
-29,839
| Closed | -$4.58M |
|
833
Rambus
RMBS
$9.01B
| – | – |
-25,227
| Closed | -$1.62M |
|
834
ResMed
RMD
$33.1B
| – | – |
-112,977
| Closed | -$29.1M |
|
835
Rimini Street
RMNI
$428M
| – | – |
-19,483
| Closed | -$73.5K |
|
|
RNAM
836
DELISTED
Avidity Biosciences
RNAM
| – | – |
-101,355
| Closed | -$2.88M |
|
837
RingCentral
RNG
$6.05B
| – | – |
-123,737
| Closed | -$3.51M |
|
838
Rockwell Automation
ROK
$46.3B
| – | – |
-16,718
| Closed | -$5.55M |
|
839
Rollins
ROL
$16.2B
| – | – |
-3,607
| Closed | -$204K |
|
840
Roper Technologies
ROP
$38B
| – | – |
-123,577
| Closed | -$70M |
|
841
Ross Stores
ROST
$72.3B
| – | – |
-269,198
| Closed | -$34.3M |
|
842
RPM International
RPM
$12.8B
| – | – |
-38,932
| Closed | -$4.28M |
|
843
Royalty Pharma
RPRX
$26B
| – | – |
-52,605
| Closed | -$1.9M |
|
844
Reliance Steel & Aluminium
RS
$20B
| – | – |
-20,700
| Closed | -$6.5M |
|
845
Republic Services
RSG
$68.3B
| – | – |
-622,500
| Closed | -$154M |
|
846
Revvity
RVTY
$15.6B
| – | – |
-3,482
| Closed | -$337K |
|
847
Royal Bank of Canada
RY
$283B
| – | – |
-955,241
| Closed | -$126M |
|
848
Rayonier
RYN
$6.08B
| – | – |
-14,474
| Closed | -$306K |
|
849
SBA Communications
SBAC
$19.4B
| – | – |
-34,338
| Closed | -$8.06M |
|
850
Sally Beauty Holdings
SBH
$1.47B
| – | – |
-191,574
| Closed | -$1.77M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2025 Portfolio in Review
As of Q3 2025, Axa held 1,077 positions worth $199M, down 99% from $34.8B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Axa withdrew a net $35.1B in Q3 2025, closing 1,016 positions and reducing 57 holdings. Its most notable exit was Broadcom, an estimated $666M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Axa added an estimated $6.03M to iShares Core MSCI Emerging Markets ETF.
- Axa added most to iShares Core MSCI Emerging Markets ETF in Q3 2025, an estimated $6.03M increase.
- Axa's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.49B.
- Axa fully exited Broadcom in Q3 2025, selling an estimated $666M.
- Axa's ten largest holdings make up 63% of its $199M portfolio in Q3 2025.
- Axa opened 0 new positions and closed 1,016 in Q3 2025.
- Axa's portfolio value fell 99% quarter-over-quarter to $199M.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.